Categories: News

Exclusively Sponsored by Sinopec’s Aipao Racing Fuel, the 2026 China Taklimakan Rally Kicks Off in Urumqi

URUMQI, China, May 18, 2026 /PRNewswire/ — With the command to start, 152 vehicles and nearly 300 competitors of 74 teams from around the world embarked on a 7,500-kilometer extreme journey as the 2026 China Taklimakan Rally, exclusively sponsored by the Aipao racing fuel brand by China Petroleum & Chemical Corporation (HKG: 0386, “Sinopec”), officially kicked off on May 16 in Urumqi, Xinjiang Uygur Autonomous Region, China.

- Advertisement -

Spanning 17 days, this year’s rally sets a new distance record as it traverses northern and southern Xinjiang. The route begins in Urumqi, passes through Turpan, Bayingolin Mongol Autonomous Prefecture, Hotan, and Kashi, and concludes in Aksu. Competitors will tackle extreme terrain, including the vast Taklimakan Desert and the rugged canyons of the Tianshan Mountains.

- Advertisement -

Aipao 103, China’s first domestically developed racing fuel by Sinopec, is the official fuel for the China Taklimakan Rally. With an RON exceeding 103, the fuel offers four core advantages of anti-knock performance, environmental friendliness, high combustion efficiency, and safety. Designed for extreme racing conditions, it fills a long-standing gap in China’s high-performance racing fuel market and marks a major milestone for Sinopec and China’s refining industry toward world-class standards.

- Advertisement -

Chen Yanbin, director and senior vice president of Sinopec, highlighted Xinjiang’s strategic role as the core area of the Silk Road Economic Belt and the rally’s status as a world-class off-road event.

- Advertisement -

“Guided by our commitment to ‘Clean Energy, Better Life,’ Sinopec continues to sponsor the rally through the Aipao brand, delivering comprehensive fuel assurance for China’s motorsport,” said Chen. “Going forward, we will deepen the integration of energy, sports, and tourism to drive high-quality growth in Xinjiang and contribute to the Belt and Road Initiative.”

- Advertisement -

To ensure seamless operations, Sinopec has comprehensively upgraded its energy support system, deploying over 40 mobile refueling points along the route. An innovative “fixed + mobile” dual-mode strategy guarantees precise, timely, and safe fuel supply—even in the most remote desert sections.

- Advertisement -

Since its launch in 2015, Aipao has earned the trust of over 10 million users with its world-class cleanliness and performance. The brand, valued at more than 18 billion yuan (approx. USD 2.64 billion), continues to lead China’s fuel market in influence.

- Advertisement -

For more information, please visit http://www.sinopec.com/listco/en/.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2981807/image1.jpg
Logo – https://mma.prnewswire.com/media/960416/SINOPEC_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/exclusively-sponsored-by-sinopecs-aipao-racing-fuel-the-2026-china-taklimakan-rally-kicks-off-in-urumqi-302774370.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

14 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

18 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

18 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

18 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

18 hours ago